ONLY AVAILABLE ON LINE |
|
Program Sessions (On demand) |
|
| On demand | The role of associations as industry growth drivers: achivements & future strategies (more info) |
| Moderator: Ion Arocena. Managing Director. AseBio (Spain)
Joseph Damond. Deputy Chief of Policy & Executive VP, International Affairs. BIO (USA) |
|
| On demand | Hospitals dynamizing the biotech industry (more info) |
| Moderator: Diego Velasco. Head of Innovation. Ramon y Cajal Research Institute (Spain)
Diego Velasco. Head of Innovation. Ramon y Cajal Research Institute (Spain) |
|
| On demand | Focus on spain: biotech clusters and regional strategies |
| Moderator: Izaskun Goñi. Directora general de Política de Empresa, Proyección Internacional y Trabajo (Spain)
Melqui Calzado. Secretary General. CataloniaBIO & HealthTech (Spain) |
|
| On demand | Navarra, 20 años apostando por el sector salud |
| Moderator: Pilar Irigoien. Directora Gerente. SODENA (Spain)
Francisco José Aranda Campos. Market Access & Quality Corporate Director, CINFA GROUP (Spain) |
|
| On demand | Company presentations |
| ADL BIOPHARMA ADNTRO GENETICS AIN-ASOCIACIÓN DE LA INDUSTRIA NAVARRA ALGAENERGY ALLADVICE REGULATORY CONSULTANTS ÄMSBIOPHARMA ASPHALION AZUR GLOBAL NUTRITION BIOMÉRIEUX BIOREPOS BIOTECNOFE CELLAB CELTARYS CENER BIO2C CLAVE MAYORCOOL CHAIN LOGISTICS DIVERSA TECHNOLOGIES ENFORCED LABORATORY UNIVERSAL FLOMICS BIOTECH FUNDACIÓN MEDINA GALARIA GATE2BRAIN, S.L. INHIBITEC ANTICUERPOS, S.L. IQS ISERN PATENTES Y MARCAS MICHROMA NATUREMIMETIX NOWTURE SL NUCAPS NANOTECHNOLOGY, S.L. NUTRICIÓN 3G PROTOQSAR 2000 VIVEBIOTECH ZECLINICS |
|
| On demand | Academic/Business plan company presentations |
| ACADEMIC PRESENTATIONS FLOMICS BIOTECH HYPERBOLA CLOUD KEY BIOLOGICAL BUSINESS PLAN COMPANY PRESENTATIONS ABILITY PHARMACEUTICALS, SL AINIA ARTHEX BIOTECH S.L. BFLOW CRAZY SCIENCE AND BUSINESS INCLIVA INHIBITEC ANTICUERPOS INNOUP FARMA LENTISTEM BIOTECH LIMNOPHARMA LINKNOVATE NEUROFIX PULEXLAB VAXDYN |
|
| On demand | Clusters/Country Presentations |
| ARGENTINA ASTUREX BASQUE HEALTH CLUSTER BIOGA BIOPARTNER UK BIOVAL CASTILLA Y LEON INNOVMEDICA POLEURO INVEST IN SPAIN |
|
ONLY AVAILABLE ON LINE |
|||
| 09:00-18:00 | VIRTUAL EXHIBITION | ||
| 09:00-00:00 | VIRTUAL PARTNERING |
||
Program Sessions |
|||
| 11:30-12:30 | SESSION Cell Therapy Manufacturing Trends and Drivers for Success  (more info) |
||
| Antoine Heron. Cell Therapy Bioprocessing Group. Gene Editing and Novel Modalities. Merck Life Science (France) |
|||
| 16:00-17:00 | SESSION Genome Project-write: An international collaboration project (more info) |
||
| Moderator: Juanjo Rubio. Navarre’s Social Innovation Unit (Spain)
George Church. Ph.D. Founding Core Faculty Members Wyss Institute at Harvard University.(U.S.A.)
|
|||
ONLY AVAILABLE ON LINE |
||
| 09:00-17:30 | VIRTUAL EXHIBITION | |
| 09:00-00:00 | VIRTUAL PARTNERING |
|
Program Sessions (streaming) |
|
| 10:00-11:00 | SESSION Talent attraction  (more info) |
| Moderator: Tomás Alarcón. Human Resources Director, 3P Biopharmaceuticals. (Spain)
Elena Rivas. CEO / Vice-President of the Spanish Biotechnological Companies Association – AseBio (Spain) |
|
| 11:30-12:45 | SESSION How gender diversity can improve Biomedicine (more info) |
| Moderator: Simón Perera. General Secretary. PRISMA (Spain)
María José Rementería. Social Link Tics Team Leader. Barcelona Supercomputing Center (Spain) |
|
| 13:00-13:30 | SESSION Patient centricity in clinical trials: challenges and lessons learned  (more info) |
| Gonzalo Peral. Business Development Manager, World Courier Spain (Spain) |
|
| 20:30-22:30 | Investors & Sponsors Reception |
| AVAILABLE ON LINE & ON SITE (confirmation through the registration form is compulsory) |
||
| 09:00-18:00 | VIRTUAL EXHIBITION | |
| 09:00-00:00 | VIRTUAL PARTNERING |
|
Track 1: Health
|
Track 2: Agro-Food-Bioeconomy
|
||
| 09:00-10:15 | SESSION Are we ready for the next pandemic? (more info) |
09:00-09:30 | SESSION PRESENTACIÓN DEL PROYECTO COMPITTE Madrid Norte – Fundacion Universidad Autónoma de Madrid |
| Anticipating future scenarios
Moderator: María Isabel Rodrigo. Deputy Director for Outpatient Processes and Diagnosis. Navarra Hospital Complex (Spain) Antonio Lopez Navas. Spain’s National Plan Against Antibiotic Resistance- PRAN AEMPS (Spain) Biotech solutions for an effective response Moderator: María Isabel Rodrigo. Deputy Director for Outpatient Processes and Diagnosis. Navarra Hospital Complex (Spain) Alexander (Sandy) Douglas. Research Group Leader at the University of Oxford, UK |
Ana Méndez. Industrial and Intellectual Property. Fundación de la Universidad Autónoma de Madrid (FUAM) (Spain) Carlos López. Innovation and Project Management. Fundación de la Universidad Autónoma de Madrid (FUAM) (Spain) |
||
| 09:45-10:45 | SESSION Getting involved in the European Climate Change Pact  (more info) |
||
| Welcome message: ASEBIO Moderator: María Segura Fornieles. Subdirectora General y Directora Técnica. AlgaEnergy (Spain)Enrique Espí Guzmán. Repsol Technology Lab (Spain) Lorena Tudela Marco. Servicio de Estudios Agroalimentarios del Grupo Cooperativo Cajamar (Spain) Javier Gil. Director Biomass Department. CENER (Spain) Celsa Monrós Barahona. Director General of Climate Change. Ambiental Educators Association/Environmental Education Center of Valencia (CEACV), Regional Valencian Ministry of Agriculture, Natural Environment, Climatic Emergency and Ecological Transition (Spain) Manuel Parga. Director of Marketing and Head of Sustainability of the Spanish Olympic Committee – Ambassador of the Climate Pact (Spain) Katerina Fortun. DG “Climate Action” (CLIMA) / EC Representative (DG Clima), European Commission (Belgium) |
|||
| 10:15-11:15 | SESSION Vaccines: Covid-19 & Beyond  |
11:00-12:00 | SESSION Bioproducts: paving the way for a sustainable planet  (more info) |
| Moderator: José Escribano. CSO. ALGENEX – Alternative Gene Expression (Spain)
Mariano Esteban. Chief Researcher Poxvirus & Vaccines Group. National Biotechnology Center-CSIC (Spain) |
Moderator: Inés del Campo. Senior R&D Engineer at the National Renewable Energy. CENER (Spain)
Begoña Ruiz. AINIA (Spain) |
||
| 11:15-12:00 | Institutional Welcome Remarks |
||
| Ana Polanco. President. AseBio – Spanish Bioindustry Association (Spain) Xiana Méndez. Secretary of State for Trade, Government of Spain María Chivite. Presidenta de la Comunidad Foral de Navarra (Spain) |
|||
| 12:00-12:30 | BREAK | ||
| 12:30-13:15 | SESSION Development and production of monoclonal antibodies   (more info) |
12:30-13:15 | SESSION Farm to fork: challenges & opportunities  (more info) |
| Moderator: Elena Erroba. Business Development Director, 3P Biopharmaceuticals (Spain)
Mark Wright. Head of Manufacturing, Nordic Nanovector (Norway) |
Moderator: César Marcos Cabañas. Coordinator & Communications Manager, ALAS / Reporter on El Economista (Spain)
María Segura Fornieles. Subdirectora General y Directora Técnica. AlgaEnergy (Spain) |
||
| 13:15-14:30 | SESSION Challenges of Preclinical Research in Spain  (more info) |
13:30-14:30 | SESSION Where do we stand on new genomic editing techniques? (more info) |
| Moderator: Amelia Martín Uranga. Clinical and traslational research Associate Director. Farmaindustria (Spain)
Anabel Sanz. Head of Tech Transfer, CRG (Spain) |
Moderator: Gerardo Pisabarro. Professor of Genetics and Plant Breeding. Public University of Navarra (Spain)
Esperanza Orellana. Director General of Agricultural Productions and Markets. Ministerio de Agricultura, Pesca y Alimentación (Spain) |
||
| 14:30-16:00 | BREAK | ||
| 16:00-17:00 | SESSION Innovations in high throughput screening platforms   (more info) |
16:00-17:00 | SESSION The Future of Food: what we will be eating in 2030 thanks to biotechnology (more info) |
| Moderator: Gijs J. Jochems. General Manager. Promega Biotech Ibérica S.L.Spain
Cell sensing: Dynamic film about cell feeling |
Moderator: Bosco Emparanza. CEO. MOA Foodtech (Spain)
Goyo Sanzol. CEO. Pentabiol (Spain) |
||
| 17:00-18:00 | SESSION Big Data & AI: : Re-shaping the Life Sciences sector |
17:15-18:00 | SESSION Microbiome (more info) |
| Moderator: Carlos López Molina. Professor. Department of Statistics, Informatics and Mathematics. Public University of Navarra (Spain)
Simón Perera. Business Development Manager. ProtoQSAR (Spain) |
Moderator: Daniel Ramon. CEO. ADM Biopolis (Spain)
Isabelle de Cremoux. CEO and Managing Partner. Targedys / Seventure Partners (France) |
||
| 19:00-20:00 | Networking Event Fronton Labrit (Calle Juan de Labrit, S/N) |
||
| 20:00-00:00 | Pintxo’s Route Downtown Pamplona | ||
|
AVAILABLE ON LINE & ON SITE
|
||
| 09:00-18:00 | VIRTUAL EXHIBITION | |
| 09:00-00:00 | VIRTUAL PARTNERING |
|
Track 1: Health
|
Track 2: Finance-Investment
|
||
| 09:00-09:45 | SESSION Paving the road from bech to bedside in ATMPs  (more info) |
09:00-09:45 | SESSION Transforming knowledge into innovative solutions: the key role of VC  (more info) |
| Moderator: Lidia Canovas. General Manager, Regulatory Affairs. ASPHALION (Spain)
Mariano García. RedTerCel (Spain) |
Moderator: Angel Peña. Journalist for Actualidad Económica, economic weekly of the daily El Mundo (Spain)
Luis Pareras. Managing Partner / Founder. Invivo Ventures / Healthequity (investor) (Spain) |
||
| 10:00-10:45 | SESSION Therapeutic adaptation to individualized patients needs: a collaborative approach for early adoption of new solutions  |
10:00-10:45 | SESSION Venture Capital  (more info) |
| Moderator: Patricia Fernandez Liz. Director Service Area – Galician Innovation Agency. Galician Innovation Agency – GAIN (Spain)
Desiree Teijeiro. COO. Libera Bio (Spain) |
Moderator: Alberto Sanz. Director of Financing & Investor Relations. ICEX-Invest in Spain (Spain)
Raúl Martín. Partner. Ysios Capital Partners (Spain) |
||
| 10:45-11:15 | SESSION Hong Kong biomedical Cluster&Leading IPO center in Asia  (more info) |
||
| Gregory Rall. Senior Manager Innovation & Technology. InvestHK Berlin (Germany) Fernando de la Cal González. Deputy Head, Investment Promotion. InvestHK Brussels (Belgium) |
|||
| 11:00-11:45 | SESSION Main aspects to be considered for gene therapies developement  (more info) |
11:15-12:00 | SESSION IPO’s fueling the growth of biotech companies  |
| Moderator: Gurutz Linazasoro. CEO. VIVEbiotech (Spain)
Massimo Dominici. Scientific Founder. Rigenerand (Italy) |
Moderator: Susana de Antonio. Head of Listing Spain. Euronext (Spain)
Sara Secall. Inveready (Spain) |
||
| 11:45-12:15 | BREAK | ||
| 12:15-13:00 | SESSION Time for HOPE? Precision Medicine in Modern Psychiatry and Neurodevelopmental disorders  (more info) |
12:30-13:15 | SESSION Impulso del I+D+I a través de nuevos modelos innovadores de financiación  |
| Moderator: Tamara Maes. Co-Founder, VP of the Board of Directors and President of the Scientific Advisory Board of Oryzon Genomics (Spain)
Josep Antoni Ramos-Quiroga. Head of Department of Psychiatry. Department of Psychiatry. CIBERSAM. Hospital Universitari Vall d’Hebron, Barcelona (Spain) |
Moderator: Raquel Saiz. Directora de Análisis y Estrategia. AseBio (Spain)
Santiago Lozano. Tech Transfer Ventures Funds Manager. Clave (Spain) |
||
| 13:15-14:00 | SESSION Retos y oportunidades en el acceso y abordaje del cáncer |
13:15-14:00 | SESSION Gipuzkoa, growth path to become a world reference in advanced therapies   (more info) |
| Moderator: Marisa Garcia Vaquero. Directora de Market Access y Corporate Affairs. Merck España (Spain)
Jesús García Foncillas. Director de la cátedra Merck. UAM (Spain) |
Moderator: Angel Sánchez. Partner. SILO (Spain)
Iker Estensoro. Director of Economic Promotion. Provincial Council of Gipuzkoa (Spain) |
||
| 14:00-15:30 | BREAK | ||
| 15:30-16:15 | SESSION Developing the next wave of diagnostic innovations: Gearing toward personalized medicine  (more info) |
16:00-17:00 | SESSION Nextgen Funds |
| Moderator: Victor González. Director of R&D. Atrys (Spain)
Beatriz Maroto. Chief Operating Officer. AMADIX (Spain) |
Moderator: Juan Luis Romera. Técnico/Asesor/Gestor en el Departamento de Promoción Institucional y Cooperación Territorial. CDTI (Spain)
Carlos Artal. Managing Director. Ayming (Spain)
|
||
| 16:15-17:00 | SESSION Harnessing the opportunities of a new era in medicine: Personalized Medicine Strategies  (more info) |
||
| Moderator: Fina Lladós. General Manager. Amgen (Spain)
Juan Cruz Cigudosa. Consejero de Universidad, Innovación y Transformación Digital. Gobierno de Navarra (Spain) |
|||
| 17:00-18:00 | SESSION Partnership as a competitive strength: Immunotherapy & Oncology |
||
| 17:00-18:00 | SESSION CRISPR: the next frontier in biotechnology (more info) |
|
Moderator: TBA
Julio Castro. CEO. Palobiofarma (Spain) |
| Moderator: Melqui Calzado. Secretary General. CataloniaBIO & HealthTech (Spain)
Javier Terriente. CEO, ZeClinics (Spain) |
|||
| 18:00-18:30 | CLOSING REMARKS |
|
|
| Mikel Irujo. Regional Minister of Economic & Business Development, Government of Navarre Diana Morant. Minister of Science & Innovation, Government of Spain |
|||
October 1st, Friday |
||
| ONLY AVAILABLE ON LINE |
||
| 09:00-17:30 | VIRTUAL EXHIBITION | |
| 09:00-00:00 | VIRTUAL PARTNERING |
|
